Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Henry Boom

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC functionNicole D Pecora, Adam J Gehring, David H Canaday, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processingAdam J Gehring, Karen M Dobos, John T Belisle, et al.
Infection and Immunity|January 25, 2005
Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturationLakshmi Ramachandra, Jamie L Smialek, Sam S Shank, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoproteinMeghan E Pennini, Yi Liu, Jianqi Yang, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2015
Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnosesSam Ogwang, Paul Mubiri, Charles M Bark, et al.
Infection and Immunity|October 16, 2002
ATP and control of intracellular growth of mycobacteria by T cellsDavid H Canaday, Reza Beigi, Richard F Silver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2012
TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9Yi C Liu, Daimon P Simmons, Xiaoxia Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2015
Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected MacrophagesJaffre J Athman, Ying Wang, David J McDonald, et al.
Infection and Immunity|November 28, 2007
Modulation of pulmonary dendritic cell function during mycobacterial infectionMursalin M Anis, Scott A Fulton, Scott M Reba, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxisSam Ogwang, Caryn E Good, Brenda Okware, et al.
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC functionNicole D Pecora, Adam J Gehring, David H Canaday, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processingAdam J Gehring, Karen M Dobos, John T Belisle, et al.
Infection and Immunity|January 25, 2005
Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturationLakshmi Ramachandra, Jamie L Smialek, Sam S Shank, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoproteinMeghan E Pennini, Yi Liu, Jianqi Yang, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2015
Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnosesSam Ogwang, Paul Mubiri, Charles M Bark, et al.
Infection and Immunity|October 16, 2002
ATP and control of intracellular growth of mycobacteria by T cellsDavid H Canaday, Reza Beigi, Richard F Silver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2012
TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9Yi C Liu, Daimon P Simmons, Xiaoxia Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2015
Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected MacrophagesJaffre J Athman, Ying Wang, David J McDonald, et al.
Infection and Immunity|November 28, 2007
Modulation of pulmonary dendritic cell function during mycobacterial infectionMursalin M Anis, Scott A Fulton, Scott M Reba, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxisSam Ogwang, Caryn E Good, Brenda Okware, et al.
Pageof 19